BCL2 and amyotrophic lateral sclerosis: Next, western blot analysis showed that after treatment with LDN-212320, the level of EAAT2 protein was significantly upregulated (Figure 8F-G), and the ratio of Bax/Bcl-2 was significantly decreased in YAPGFAP-CKO ALS mice (Figure 8F, H).